Reumatoloxía

2016

1. 3, 3′, 5-triiodo-L-thyronine Increases In Vitro Chondrogenesis of Mesenchymal Stem Cells From Human Umbilical Cord Stroma Through SRC2

   Journal of Cellular Biochemistry, pp. 2097-2108

2. A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis

   PLoS ONE, Vol. 11, Núm. 7

3. A functional variant of TLR10 modifies the activity of NFkB and may help predict a worse prognosis in patients with rheumatoid arthritis

   Arthritis Research and Therapy, Vol. 18, Núm. 1

4. A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis

   Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1106-1111

5. A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis

   Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 147-150

6. A methodological approach based on gold-nanoparticles followed by matrix assisted laser desorption ionization time of flight mass spectrometry for the analysis of urine profiling of knee osteoarthritis

   Talanta, Vol. 150, pp. 638-645

7. A survey of anatomical items relevant to the practice of rheumatology: upper extremity, head, neck, spine, and general concepts

   Clinical Rheumatology, Vol. 35, Núm. 12, pp. 3025-3030

8. Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies

   PLoS ONE, Vol. 11, Núm. 8

9. Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review

   Rheumatology International, Vol. 36, Núm. 8, pp. 1043-1063

10. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: A phase III, randomised, controlled trial (PALACE 3)

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 6, pp. 1065-1073

11. Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development

    American Journal of Transplantation, Vol. 16, Núm. 9, pp. 2574-2588

12. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

    Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344

13. CRONIGAL: Prognostic index for chronic patients after hospital admission

    European Journal of Internal Medicine, Vol. 36, pp. 25-31

14. Centre characteristics determine ambulatory care and referrals in patients with spondyloarthritis

    Rheumatology International, Vol. 36, Núm. 11, pp. 1515-1523

15. Centre-related variability in hospital admissions of patients with spondyloarthritis

    Rheumatology International, Vol. 36, Núm. 9, pp. 1301-1308

16. Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)

    Medicine (United States), Vol. 95, Núm. 9

17. Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management

    Medicina Clinica

18. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: A multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 37-44

19. Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study

    Arthritis Research and Therapy, Vol. 18, Núm. 1

20. Consensus statement on the management of comorbidity in patients with rheumatoid arthritis and psoriasis

    Journal of Rheumatology